Cargando…

Evaluation of the Procleix Ultrio Plus ID NAT assay for detection of HIV 1, HBV and HCV in blood donors

INTRODUCTION: The Procleix Ultrio Plusassay is a new-generation qualitative in vitro nucleic acid amplification test used to screen for human immunodeficiency virus type 1 (HIV-1) RNA, hepatitis C virus (HCV) RNA and hepatitis B virus (HBV) DNA in blood donors. This study was performed to compare th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makroo, Raj Nath, Chowdhry, Mohit, Bhatia, Aakanksha, Antony, Minimol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339927/ https://www.ncbi.nlm.nih.gov/pubmed/25722569 http://dx.doi.org/10.4103/0973-6247.150944

Ejemplares similares

Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India
por: Chaurasia, Rahul, et al.
Publicado: (2016)

Evaluation of the Aptima HBV Quant Assay Compared to Abbott RealTime M2000 HBV Quant Assay and Procleix Ultrio Plus dHBV Assay in Plasma Samples
por: Yan, Ying, et al.
Publicado: (2022)

Nearly half of Ultrio plus NAT non-discriminated reactive blood donors were identified as occult HBV infection in South China
por: Ye, Xianlin, et al.
Publicado: (2019)

Seroprevalence of anti-HCV antibodies among blood donors of north India
por: Makroo, R.N., et al.
Publicado: (2013)

Frequency of Mi(a) antigen: A pilot study among blood donors
por: Makroo, Raj Nath, et al.
Publicado: (2016)

Clinical significance of antibody specificities to M, N and Lewis blood group system
por: Makroo, Raj Nath, et al.
Publicado: (2014)

Impact of antigenic exposures and role of molecular blood grouping in enhancing transfusion safety in chronically transfused thalassemics
por: Makroo, Raj Nath, et al.
Publicado: (2016)

Red cell alloimmunization & role of advanced immunohaematological support in liver transplantation
por: Makroo, Raj Nath, et al.
Publicado: (2017)

Preoperative predictors of blood component transfusion in living donor liver transplantation
por: Makroo, R. N., et al.
Publicado: (2013)

Prevalence of HIV among blood donors in a tertiary care centre of north India
por: Makroo, R.N., et al.
Publicado: (2011)

Hepatitis B core antibody testing in Indian blood donors: A double-edged sword!
por: Makroo, R. N., et al.
Publicado: (2012)

Seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north india
por: Makroo, R.N., et al.
Publicado: (2015)

Weak D prevalence among Indian blood donors
por: Makroo, R. N., et al.
Publicado: (2010)

Antibody screening & identification in the general patient population at a tertiary care hospital in New Delhi, India
por: Makroo, Raj Nath, et al.
Publicado: (2014)

A multivariate analysis to assess the effect of packed red cell transfusion and the unit age of transfused red cells on postoperative complications in patients undergoing cardiac surgeries
por: Makroo, Raj Nath, et al.
Publicado: (2015)

Delta check for blood groups: A step ahead in blood safety
por: Makroo, Raj Nath, et al.
Publicado: (2017)

Prevalence of irregular red cell antibody in healthy blood donors attending a tertiary care hospital in North India
por: Makroo, Raj Nath, et al.
Publicado: (2018)

Evaluation of bacterial inactivation in random donor platelets and single-donor apheresis platelets by the INTERCEPT blood system
por: Makroo, Raj Nath, et al.
Publicado: (2018)

An Improved NAT Assay with Enhanced Sensitivity for HBV for Donor Blood Screening
por: Chatterjee, Kabita
Publicado: (2012)

Donated Blood Screening for HIV, HCV and HBV by ID-NAT and the Residual Risk of Iatrogenic Transmission in a Tertiary Care Hospital Blood Bank in Puebla, Mexico
por: Sosa-Jurado, Francisca, et al.
Publicado: (2023)

Effectiveness of blood donor screening by HIV, HCV, HBV‐NAT assays, as well as HBsAg and anti‐HBc immunoassays in Germany (2008–2015)
por: Fiedler, Sarah A., et al.
Publicado: (2019)

Prevalence of Occult Hepatitis B Virus Infection in Blood Donors with Negative ID-NAT in Switzerland
por: Zbinden, Andrea, et al.
Publicado: (2022)

Prevalence of Rh, Duffy, Kell, Kidd & MNSs blood group antigens in the Indian blood donor population
por: Makroo, R.N., et al.
Publicado: (2013)

Prevalence of HBV and HCV among blood donors in Kosovo
por: Fejza, Hajrullah, et al.
Publicado: (2009)

A positive complement dependent cytotoxicity immunoglobulin G crossmatch due to auto-antibodies with a negative luminex bead assays in a renal transplant recipient: A Diagnostic dilemma
por: Chowdhry, Mohit, et al.
Publicado: (2018)

Anti-G antibody in alloimmunized pregnant women: Report of two cases
por: Makroo, Raj Nath, et al.
Publicado: (2015)

Therapeutic leukapheresis in a tertiary care hospital: A case series
por: Makroo, Raj Nath, et al.
Publicado: (2017)

Clinicohematological correlation and chromosomal breakage analysis in suspected Fanconi anemia patients of India
por: Chowdhry, Mohit, et al.
Publicado: (2014)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

ABO incompatible renal transplant: Transfusion medicine perspective
por: Makroo, Raj Nath, et al.
Publicado: (2017)

Role of therapeutic plasma exchange in acute humoral rejection patients undergoing live-related renal transplantation: A single-center experience
por: Kakkar, Brinda, et al.
Publicado: (2021)

HBV and HCV Therapy
por: Lampertico, Pietro, et al.
Publicado: (2009)

Co-infection rate of HIV, HBV and Syphilis among HCV seropositive identified blood donors in Kathmandu, Nepal
por: Shrestha, Ashish Chandra, et al.
Publicado: (2012)

PI-5 The seropositivity of HBV, HCV, HIV among blood donors in Istanbul, Turkey
por: Aydin, O.A., et al.
Publicado: (2009)

Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali
por: Jary, Aude, et al.
Publicado: (2019)

Prevalence, incidence and residual risk of transfusion-transmitted HBV infection before and after the implementation of HBV-NAT in northern Brazil
por: Corrêa, Angelita Silva de Miranda, et al.
Publicado: (2018)

Prevalence of HBV and HCV Infections in Iranian Blood Donors; An Updated Systematic Review and Meta-Analysis
por: Kasraian, Leila, et al.
Publicado: (2021)

Role of signal-to-cut-off ratios of anti-hepatitis C virus antibody by enzyme immunoassays along with ID-NAT for screening of whole blood donors in India
por: Arora, Satyam, et al.
Publicado: (2016)

HBV and HCV Infection in Children and Adolescents
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2023)

Clinical evaluation of the Procleix SARS-CoV-2 assay, a sensitive, high-throughput test that runs on an automated system
por: Sauleda, Silvia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gb712k9jkhkk6830i45fl21oes